Addus HomeCare Co. (NASDAQ:ADUS) hit a new 52-week high on Thursday . The company traded as high as $117.79 and last traded at $117.00, with a volume of 2070 shares trading hands. The stock had previously closed at $116.02.
A number of research analysts recently commented on the stock. Zacks Investment Research upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating and set a $113.00 price objective on the stock in a research note on Monday, November 16th. BidaskClub raised Addus HomeCare from a “hold” rating to a “buy” rating in a report on Friday, December 18th. Finally, Oppenheimer reissued a “buy” rating on shares of Addus HomeCare in a research report on Thursday, October 1st. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $109.33.
The company has a market capitalization of $1.85 billion, a P/E ratio of 60.11, a PEG ratio of 2.82 and a beta of 0.61. The firm has a 50-day moving average price of $105.11 and a two-hundred day moving average price of $97.73. The company has a quick ratio of 3.19, a current ratio of 3.19 and a debt-to-equity ratio of 0.12.
In other news, COO W Bradley Bickham sold 15,000 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $105.71, for a total transaction of $1,585,650.00. Following the transaction, the chief operating officer now directly owns 43,968 shares in the company, valued at approximately $4,647,857.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP David W. Tucker sold 268 shares of the company’s stock in a transaction dated Monday, November 30th. The shares were sold at an average price of $95.56, for a total transaction of $25,610.08. Following the completion of the transaction, the executive vice president now owns 6,937 shares in the company, valued at approximately $662,899.72. The disclosure for this sale can be found here. Insiders have sold a total of 530,377 shares of company stock valued at $53,509,708 over the last 90 days. Corporate insiders own 6.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Marshall Wace North America L.P. bought a new position in Addus HomeCare during the 1st quarter worth approximately $34,000. Point72 Hong Kong Ltd boosted its position in Addus HomeCare by 96.8% in the third quarter. Point72 Hong Kong Ltd now owns 370 shares of the company’s stock worth $35,000 after purchasing an additional 182 shares during the last quarter. Nisa Investment Advisors LLC grew its position in Addus HomeCare by 133.3% during the third quarter. Nisa Investment Advisors LLC now owns 700 shares of the company’s stock valued at $66,000 after buying an additional 400 shares during the period. US Bancorp DE grew its holdings in Addus HomeCare by 87.7% during the third quarter. US Bancorp DE now owns 858 shares of the company’s stock valued at $81,000 after purchasing an additional 401 shares during the period. Finally, UBS Group AG raised its stake in Addus HomeCare by 71.6% in the 2nd quarter. UBS Group AG now owns 1,306 shares of the company’s stock valued at $121,000 after acquiring an additional 545 shares during the period. Institutional investors and hedge funds own 84.78% of the company’s stock.
About Addus HomeCare (NASDAQ:ADUS)
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Further Reading: Strangles
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.